MYOV Overview
Upcoming Projects (MYOV)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (MYOV)
-
A second look: Discussing the use of Orgovyx(relugolix), a gonadotropin-releasing hormone (GnRH) receptor antagonist, for adult patients with prostate cancer
Ticker: MYOV
Executed On: Feb 22, 2023 at 02:00 PM EST -
Discussing the use of Orgovyx(relugolix), a gonadotropin-releasing hormone (GnRH) receptor antagonist, for adult patients with prostate cancer
Ticker: MYOV
Executed On: Jan 27, 2023 at 01:30 PM EST -
A Third Look: Discussing the standard of care and use of Myfembree in treating endometriosis
Tickers: PFE, MYOV
Executed On: Aug 19, 2022 at 03:00 PM EDT -
A Second Look: Discussing the standard of care and use of Myfembree in treating endometriosis
Tickers: PFE, MYOV
Executed On: Aug 18, 2022 at 09:00 AM EDT -
Discussing the standard of care and use of Myfembree in treating endometriosis
Tickers: PFE, MYOV
Executed On: Aug 10, 2022 at 04:30 PM EDT
Upcoming & Overdue Catalysts (MYOV)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (MYOV)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
